Introduction & Objective: Glucose intolerance is common in pregnancy but incompletely characterized. We used continuous glucose monitor (CGM)-derived metrics to assess dysglycemia amongst pregnant individuals with a varying levels of glucose intolerance.

Methods: In this prospective observational study, pregnant individuals between 24-32 weeks gestation with no history of pregestational diabetes wore blinded CGM for up to 10 days. Participants were separated into four cohorts: normal 1-hour glucose challenge test (GCT), abnormal GCT and normal 3-hour oral glucose tolerance test (OGTT), abnormal GCT and 1 abnormal value on OGTT, and GDM by Carpenter-Coustan criteria. We calculated summary statistics and tested between-group differences with one-way ANOVA pair-wise comparisons with the prespecified primary outcome of time in range (TIR) within the pregnancy-specific goal of 63-140 mg/dL. We used one-way ANOVA and post-hoc tests for secondary outcomes of average glucose, time hyperglycemic, and coefficient of variation.

Results: Among 71 pregnant individuals at a mean gestational age of 29 weeks, the mean CGM use was 7.6 days. The mean time in range for the normal GCT cohort was 96.6% (95% CI 94.9-97.8%), for failed GCT/normal OGTT was 92.0% (95% CI 89.6-96%), for failed GCT/1 abnormal OGTT value was 91.8% (95% CI 83.7-95.7%), and for GDM was 92.6% (95% CI 83.9-97.9%). Normal GCT TIR was significantly different from failed GCT and 1 abnormal OGTT (p=0.04) and GDM (p= 0.04); no other pairwise comparisons of TIR were significantly different. There were no significant between-group differences for average glucose (p= 0.31), time hyperglycemic (p= 0.17), and coefficient of variation (p= 0.10).

Conclusion: Pregnant individuals with 1 abnormal OGTT value had similar TIR as those with a diagnosis of GDM. Further research is needed to determine if these individuals have clinically significant dysglycemia associated with adverse pregnancy outcomes that requires monitoring and intervention.

Disclosure

R.D. Gordon: None. J. Grasch: None. N. Nandam: Other Relationship; American Journal of Managed Care. J. Wu: None. P. Schneider: None. S.G. Gabbe: None. M.B. Landon: None. M. Costantine: None. K. Venkatesh: None. E. Buschur: Research Support; Dexcom, Inc.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.